Item Type | Name |
Academic Article
|
Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.
|
Academic Article
|
Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity.
|
Academic Article
|
WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome.
|
Academic Article
|
Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma.
|
Academic Article
|
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.
|
Academic Article
|
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
|
Academic Article
|
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.
|
Academic Article
|
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.
|
Academic Article
|
Integrative epidemiology: from risk assessment to outcome prediction.
|
Academic Article
|
Copy number imbalances between screen- and symptom-detected breast cancers and impact on disease-free survival.
|
Academic Article
|
ZNF668 functions as a tumor suppressor by regulating p53 stability and function in breast cancer.
|
Academic Article
|
Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer.
|
Academic Article
|
Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancer.
|
Academic Article
|
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.
|
Academic Article
|
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
|
Academic Article
|
The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.
|
Academic Article
|
Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.
|
Academic Article
|
Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck.
|
Academic Article
|
The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck.
|
Academic Article
|
Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells.
|
Academic Article
|
Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
|
Academic Article
|
A plant triterpenoid, avicin D, induces autophagy by activation of AMP-activated protein kinase.
|
Academic Article
|
Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3.
|
Academic Article
|
Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells.
|
Academic Article
|
Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor.
|
Academic Article
|
Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment.
|
Academic Article
|
CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.
|
Academic Article
|
Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epithelium.
|
Academic Article
|
Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer.
|
Academic Article
|
A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
|
Academic Article
|
Lysophosphatidic acid production and action: validated targets in cancer?
|
Academic Article
|
The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells.
|
Academic Article
|
Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer.
|
Academic Article
|
Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy.
|
Academic Article
|
Exploratory analysis of the copy number alterations in glioblastoma multiforme.
|
Academic Article
|
Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study.
|
Academic Article
|
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.
|
Academic Article
|
High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability.
|
Academic Article
|
Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes.
|
Academic Article
|
Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8.
|
Concept
|
Neoplasms, Basal Cell
|
Concept
|
Gastrointestinal Stromal Tumors
|
Concept
|
Thyroid Neoplasms
|
Concept
|
Nerve Sheath Neoplasms
|
Concept
|
Genital Neoplasms, Female
|
Concept
|
Central Nervous System Neoplasms
|
Concept
|
Tumor Necrosis Factors
|
Concept
|
Breast Neoplasms, Male
|
Concept
|
Mammary Neoplasms, Experimental
|
Concept
|
Mammary Tumor Virus, Mouse
|
Concept
|
Tumor Burden
|
Concept
|
Esophageal Neoplasms
|
Concept
|
Brain Neoplasms
|
Concept
|
Lung Neoplasms
|
Concept
|
Uterine Neoplasms
|
Concept
|
Neoplasms, Germ Cell and Embryonal
|
Concept
|
Tumor Suppressor Protein p53
|
Concept
|
Prostatic Neoplasms
|
Concept
|
Neoplasm Metastasis
|
Concept
|
Genes, Tumor Suppressor
|
Concept
|
Hematologic Neoplasms
|
Concept
|
Tumor Necrosis Factor Receptor Superfamily, Member 7
|
Concept
|
Mammary Neoplasms, Animal
|
Concept
|
Neoplasms, Cystic, Mucinous, and Serous
|
Concept
|
Biomarkers, Tumor
|
Concept
|
Antigens, Neoplasm
|
Concept
|
Gallbladder Neoplasms
|
Concept
|
Ovarian Neoplasms
|
Concept
|
Nasopharyngeal Neoplasms
|
Concept
|
Antigens, Tumor-Associated, Carbohydrate
|
Concept
|
Laryngeal Neoplasms
|
Concept
|
DNA, Neoplasm
|
Concept
|
Mediastinal Neoplasms
|
Concept
|
Prostatic Intraepithelial Neoplasia
|
Concept
|
Urinary Bladder Neoplasms
|
Concept
|
Uveal Neoplasms
|
Concept
|
Retroperitoneal Neoplasms
|
Concept
|
Neoplasms, Experimental
|
Concept
|
Colorectal Neoplasms
|
Concept
|
Pancreatic Neoplasms
|
Concept
|
Neoplasm Proteins
|
Concept
|
Neoplasm Staging
|
Concept
|
Tumor Escape
|
Concept
|
Kidney Neoplasms
|
Concept
|
Drug Resistance, Neoplasm
|
Concept
|
Neoplasm Transplantation
|
Concept
|
Mouth Neoplasms
|
Concept
|
Breast Neoplasms
|
Concept
|
Stomach Neoplasms
|
Concept
|
Bone Neoplasms
|
Concept
|
Tumor Stem Cell Assay
|
Concept
|
Antibodies, Neoplasm
|
Concept
|
Tumor Cells, Cultured
|
Concept
|
Head and Neck Neoplasms
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
Concept
|
Oropharyngeal Neoplasms
|
Concept
|
Neoplasms, Glandular and Epithelial
|
Concept
|
Neoplasms, Hormone-Dependent
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
Von Hippel-Lindau Tumor Suppressor Protein
|
Concept
|
Neoplasms
|
Concept
|
Skin Neoplasms
|
Concept
|
Neoplasm, Residual
|
Concept
|
Tongue Neoplasms
|
Concept
|
Colonic Neoplasms
|
Concept
|
Cell Line, Tumor
|
Concept
|
Tumor Suppressor Proteins
|
Concept
|
Neoplasm Recurrence, Local
|
Concept
|
Peritoneal Neoplasms
|
Concept
|
Genes, Neoplasm
|
Concept
|
RNA, Neoplasm
|
Concept
|
Liver Neoplasms
|
Concept
|
Uterine Cervical Neoplasms
|
Concept
|
Soft Tissue Neoplasms
|
Concept
|
Liver Neoplasms, Experimental
|
Concept
|
Neoplasm Invasiveness
|
Concept
|
Testicular Neoplasms
|
Concept
|
Endometrial Neoplasms
|
Academic Article
|
HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells.
|
Academic Article
|
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation.
|
Academic Article
|
PTK6 regulates IGF-1-induced anchorage-independent survival.
|
Academic Article
|
Exposing the cancer genome atlas as a SPARQL endpoint.
|
Academic Article
|
Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation.
|
Academic Article
|
A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.
|
Academic Article
|
Comprehensive molecular characterization of clear cell renal cell carcinoma.
|
Academic Article
|
The Cancer Genome Atlas Pan-Cancer analysis project.
|
Academic Article
|
The somatic genomic landscape of glioblastoma.
|
Academic Article
|
Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer.
|
Academic Article
|
A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes.
|
Academic Article
|
LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients.
|
Academic Article
|
Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling.
|
Academic Article
|
Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.
|
Academic Article
|
Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cells.
|
Academic Article
|
Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer.
|
Academic Article
|
Integrated genomic analyses of ovarian carcinoma.
|
Academic Article
|
Molecular characterization of gallbladder cancer using somatic mutation profiling.
|
Academic Article
|
Genome-wide transcriptome profiling of homologous recombination DNA repair.
|
Academic Article
|
Coordinate phosphorylation of multiple residues on single AKT1 and AKT2 molecules.
|
Academic Article
|
Unraveling the regulatory connections between two controllers of breast cancer cell fate.
|
Academic Article
|
Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation.
|
Academic Article
|
Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.
|
Academic Article
|
Assessing the clinical utility of cancer genomic and proteomic data across tumor types.
|
Academic Article
|
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.
|
Academic Article
|
Definition of PKC-a, CDK6, and MET as therapeutic targets in triple-negative breast cancer.
|
Academic Article
|
Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival.
|
Academic Article
|
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase.
|
Academic Article
|
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.
|
Academic Article
|
Cupid: simultaneous reconstruction of microRNA-target and ceRNA networks.
|
Academic Article
|
A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinoma.
|
Academic Article
|
Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
|
Academic Article
|
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers.
|
Academic Article
|
RET fusion as a novel driver of medullary thyroid carcinoma.
|
Academic Article
|
Functional consequence of the MET-T1010I polymorphism in breast cancer.
|
Academic Article
|
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer.
|
Academic Article
|
Human hematopoietic cell express two forms of the cytokine receptor common gamma-chain (gamma c).
|
Academic Article
|
Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
|
Academic Article
|
Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus.
|
Academic Article
|
XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
|
Academic Article
|
Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
|
Academic Article
|
Triterpenoid saponins from Acacia victoriae (Bentham) decrease tumor cell proliferation and induce apoptosis.
|
Academic Article
|
Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo.
|
Academic Article
|
Early detection of ovarian cancer: promise and reality.
|
Academic Article
|
Mechanisms underlying chemoprevention of ovarian cancer.
|
Academic Article
|
Use of proteomic patterns in serum to identify ovarian cancer.
|
Academic Article
|
Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
|
Academic Article
|
Specific keynote: molecular therapeutics in ovarian cancer.
|
Academic Article
|
The emerging role of lysophosphatidic acid in cancer.
|
Academic Article
|
Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells.
|
Academic Article
|
Determinants of rapamycin sensitivity in breast cancer cells.
|
Academic Article
|
Analysis of molecular aberrations in ovarian cancer allows novel target identification.
|
Academic Article
|
Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells.
|
Academic Article
|
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.
|
Academic Article
|
Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors.
|
Academic Article
|
Identification of remodeling and spacing factor 1 (rsf-1, HBXAP) at chromosome 11q13 as a putative oncogene in ovarian cancer.
|
Academic Article
|
Assay of Rab25 function in ovarian and breast cancers.
|
Academic Article
|
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers.
|
Academic Article
|
Ovarian cancer: homeobox genes, autocrine/paracrine growth, and kinase signaling.
|
Academic Article
|
Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.
|
Academic Article
|
Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions.
|
Academic Article
|
An inherent role of integrin-linked kinase-estrogen receptor alpha interaction in cell migration.
|
Academic Article
|
Acquired resistance to erlotinib in A-431 epidermoid cancer cells requires down-regulation of MMAC1/PTEN and up-regulation of phosphorylated Akt.
|
Academic Article
|
Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments.
|
Academic Article
|
Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.
|
Academic Article
|
Pharmacodynamic markers of perifosine efficacy.
|
Academic Article
|
Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.
|
Academic Article
|
Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer.
|
Academic Article
|
AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27.
|
Academic Article
|
The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells.
|
Academic Article
|
Cetuximab attenuates metastasis and u-PAR expression in non-small cell lung cancer: u-PAR and E-cadherin are novel biomarkers of cetuximab sensitivity.
|
Academic Article
|
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
|
Academic Article
|
Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.
|
Academic Article
|
Gene and protein expression markers of response to combined antiangiogenic and epidermal growth factor targeted therapy in renal cell carcinoma.
|
Academic Article
|
Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells.
|
Academic Article
|
Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis.
|
Academic Article
|
Vimentin is a novel AKT1 target mediating motility and invasion.
|
Academic Article
|
Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid.
|
Academic Article
|
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death.
|
Academic Article
|
Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression.
|
Academic Article
|
Drosophila in cancer research: to boldly go where no one has gone before.
|
Academic Article
|
ERa-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer.
|
Academic Article
|
Androgen regulation of 5a-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention.
|
Academic Article
|
Rab25 increases cellular ATP and glycogen stores protecting cancer cells from bioenergetic stress.
|
Academic Article
|
An emerging toolkit for targeted cancer therapies.
|
Academic Article
|
Detection algorithm for the validation of human cell lines.
|
Academic Article
|
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition.
|
Academic Article
|
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.
|
Academic Article
|
Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo.
|
Academic Article
|
Mechanistic basis for overcoming platinum resistance using copper chelating agents.
|
Academic Article
|
Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy.
|
Academic Article
|
Rab25 in cancer: a brief update.
|
Academic Article
|
Repurposing the Pap smear: one step closer to gynecologic cancer screening.
|
Academic Article
|
Systematic identification of combinatorial drivers and targets in cancer cell lines.
|
Academic Article
|
Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer.
|
Academic Article
|
TCPA: a resource for cancer functional proteomics data.
|
Academic Article
|
Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.
|
Academic Article
|
Modeling precision treatment of breast cancer.
|
Academic Article
|
Proteomic characterization of breast cancer xenografts identifies early and late bevacizumab-induced responses and predicts effective drug combinations.
|
Academic Article
|
Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes.
|
Academic Article
|
Promising rationally derived combination therapy with PI3K and CDK4/6 inhibitors.
|
Academic Article
|
Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma.
|
Academic Article
|
Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.
|
Academic Article
|
Expression of TTK, a novel human protein kinase, is associated with cell proliferation.
|
Academic Article
|
Expression of ras oncogene leads to down-regulation of protein kinase C.
|
Academic Article
|
Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells.
|
Academic Article
|
Inhibition of stimulus-dependent epidermal growth factor receptor and transforming growth factor-alpha mRNA accumulation by the protein kinase C inhibitor staurosporine.
|
Academic Article
|
A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action.
|
Academic Article
|
CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line.
|
Academic Article
|
Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro.
|
Academic Article
|
CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response.
|
Academic Article
|
Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients.
|
Academic Article
|
The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28.
|
Academic Article
|
Expression of p16 induces transcriptional downregulation of the RB gene.
|
Academic Article
|
p202 prevents apoptosis in murine AKR-2B fibroblasts.
|
Academic Article
|
Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.
|
Academic Article
|
Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
|
Academic Article
|
NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas.
|
Academic Article
|
PIK3CA is implicated as an oncogene in ovarian cancer.
|
Academic Article
|
Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
|
Academic Article
|
The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression.
|
Academic Article
|
Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.
|
Academic Article
|
Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
|
Academic Article
|
In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002).
|
Academic Article
|
Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.
|
Academic Article
|
Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2.
|
Academic Article
|
A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells.
|
Academic Article
|
Inhibition of growth-factor-induced phosphorylation and activation of protein kinase B/Akt by atypical protein kinase C in breast cancer cells.
|
Academic Article
|
Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells.
|
Academic Article
|
Genetic analysis of early- versus late-stage ovarian tumors.
|
Academic Article
|
Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2.
|
Academic Article
|
Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
|
Academic Article
|
Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers.
|
Academic Article
|
General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer.
|
Academic Article
|
Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.
|
Academic Article
|
Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase-dependent Pathways cooperate to maintain lung cancer cell survival.
|
Academic Article
|
ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers.
|
Academic Article
|
Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
|
Academic Article
|
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer.
|
Academic Article
|
Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias.
|
Academic Article
|
Promising directions for the diagnosis and management of gynecological cancers.
|
Academic Article
|
Molecular therapeutics: promise and challenges.
|
Academic Article
|
Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
|
Academic Article
|
Emerging role of RAB GTPases in cancer and human disease.
|
Academic Article
|
Stem cell-ness: a "magic marker" for cancer.
|
Academic Article
|
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt.
|
Academic Article
|
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages.
|
Academic Article
|
Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma.
|
Academic Article
|
Autophosphorylation of Akt at threonine 72 and serine 246. A potential mechanism of regulation of Akt kinase activity.
|
Academic Article
|
Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells.
|
Academic Article
|
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.
|
Academic Article
|
Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer.
|
Academic Article
|
The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis.
|
Academic Article
|
Prevention and early detection of ovarian cancer: mission impossible?
|
Academic Article
|
Alkoxymethylenephosphonate analogues of (Lyso) phosphatidic acid stimulate signaling networks coupled to the LPA2 receptor.
|
Academic Article
|
Opportunities and challenges in ovarian cancer research, a perspective from the 11th Ovarian cancer action/HHMT Forum, Lake Como, March 2007.
|
Academic Article
|
A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity.
|
Academic Article
|
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
|
Academic Article
|
Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer.
|
Academic Article
|
A sequence-based survey of the complex structural organization of tumor genomes.
|
Academic Article
|
Soft tissue sarcoma cells are highly sensitive to AKT blockade: a role for p53-independent up-regulation of GADD45 alpha.
|
Academic Article
|
Ovarian cancer: linking genomics to new target discovery and molecular markers--the way ahead.
|
Academic Article
|
Individualized molecular medicine: linking functional proteomics to select therapeutics targeting the PI3K pathway for specific patients.
|
Academic Article
|
Lysophosphatidic acid (LPA)-induced vasodilator-stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cells.
|
Academic Article
|
Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance.
|
Academic Article
|
Uniparental disomy in cancer.
|
Academic Article
|
Rak functions as a tumor suppressor by regulating PTEN protein stability and function.
|
Academic Article
|
Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
|
Academic Article
|
Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.
|
Academic Article
|
Genomic amplicons target vesicle recycling in breast cancer.
|
Academic Article
|
Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates.
|
Academic Article
|
The emerging role of the RAB25 small GTPase in cancer.
|
Academic Article
|
miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.
|
Academic Article
|
Ras-superfamily GTP-ases in ovarian cancer.
|
Academic Article
|
ATX-LPA receptor axis in inflammation and cancer.
|
Academic Article
|
Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer.
|
Academic Article
|
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set.
|
Academic Article
|
Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
|
Academic Article
|
Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer.
|
Academic Article
|
PI3K pathway-directed therapeutic strategies in cancer.
|
Academic Article
|
Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells.
|
Academic Article
|
Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer.
|
Academic Article
|
Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation.
|
Academic Article
|
Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis.
|
Academic Article
|
Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence.
|
Academic Article
|
Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy.
|
Academic Article
|
Quantitative proteomic analysis in breast cancer.
|
Academic Article
|
Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity.
|
Academic Article
|
PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer.
|
Academic Article
|
Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition.
|
Academic Article
|
MDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cells.
|
Academic Article
|
HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.
|
Academic Article
|
Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer.
|
Academic Article
|
Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models.
|
Academic Article
|
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.
|
Academic Article
|
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer.
|
Academic Article
|
Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.
|
Academic Article
|
Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing.
|
Academic Article
|
Agents that stabilize mutated von Hippel-Lindau (VHL) protein: results of a high-throughput screen to identify compounds that modulate VHL proteostasis.
|
Academic Article
|
cMET and phospho-cMET protein levels in breast cancers and survival outcomes.
|
Academic Article
|
PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors.
|
Academic Article
|
Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis.
|
Academic Article
|
Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML.
|
Academic Article
|
Overcoming implementation challenges of personalized cancer therapy.
|
Academic Article
|
Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.
|
Academic Article
|
Targeting the hepatocyte growth factor-cMET axis in cancer therapy.
|
Academic Article
|
Biomarkers of response to Akt inhibitor MK-2206 in breast cancer.
|
Academic Article
|
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.
|
Academic Article
|
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer.
|
Academic Article
|
EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: inhibition by resveratrol.
|
Academic Article
|
High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients.
|
Academic Article
|
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents.
|
Academic Article
|
Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520.
|
Academic Article
|
Building a personalized medicine infrastructure at a major cancer center.
|
Academic Article
|
Integrated genomic characterization of endometrial carcinoma.
|
Academic Article
|
AMPK: a contextual oncogene or tumor suppressor?
|
Academic Article
|
Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer.
|
Academic Article
|
Clinical investigation of receptor and non-receptor tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer.
|
Academic Article
|
Predicting time to ovarian carcinoma recurrence using protein markers.
|
Academic Article
|
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.
|
Academic Article
|
An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation.
|
Academic Article
|
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer.
|
Academic Article
|
Activation of YAP1 is associated with poor prognosis and response to taxanes in ovarian cancer.
|
Academic Article
|
Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.
|
Academic Article
|
Comprehensive molecular profiling of lung adenocarcinoma.
|
Academic Article
|
Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor.
|
Academic Article
|
Chronic myeloid leukemia arising in a progenitor common to T cells and myeloid cells.
|
Academic Article
|
Activation of the Na+/H+ antiport is not required for epidermal growth factor-dependent gene expression, growth inhibition or proliferation in human breast cancer cells.
|
Academic Article
|
Characterization of the requirements for human T cell mitogenesis by using suboptimal concentrations of phytohemagglutinin.
|
Academic Article
|
Interleukin 2 activates a receptor-associated protein kinase.
|
Academic Article
|
Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (Interleukin 2).
|
Academic Article
|
Lysophospholipids activate ovarian and breast cancer cells.
|
Academic Article
|
The v-raf oncogene enhances tumorigenicity and suppresses differentiation in vivo in a rat hepatocyte cell line.
|
Academic Article
|
Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites.
|
Academic Article
|
Role of aberrant sialylation of chronic myeloid leukemia granulocytes on binding and signal transduction by chemotactic peptides and colony stimulating factors.
|
Academic Article
|
Genomic components of carcinogenesis.
|
Academic Article
|
Cell cycle dependent regulation of the protein kinase TTK.
|
Academic Article
|
Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA.
|
Academic Article
|
The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.
|
Academic Article
|
Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition.
|
Academic Article
|
p202 self-associates through a sequence conserved among the members of the 200-family proteins.
|
Academic Article
|
Physiologic and pathologic drug resistance in ovarian carcinoma--a hypothesis based on a clonal progression model.
|
Academic Article
|
Markedly elevated levels of vascular endothelial growth factor in malignant ascites.
|
Academic Article
|
Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 status.
|
Academic Article
|
Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
|
Academic Article
|
Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner.
|
Academic Article
|
Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management.
|
Academic Article
|
In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299.
|
Academic Article
|
Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
|
Academic Article
|
Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics.
|
Academic Article
|
The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy.
|
Academic Article
|
Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
|
Academic Article
|
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
|
Academic Article
|
Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo.
|
Academic Article
|
Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosis.
|
Academic Article
|
Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors.
|
Academic Article
|
The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
|
Academic Article
|
Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy.
|
Academic Article
|
Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors.
|
Academic Article
|
Expression of endogenous granzyme B in a subset of human primary breast carcinomas.
|
Academic Article
|
Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust.
|
Academic Article
|
Targeting PI3K-AKT pathway for cancer therapy.
|
Academic Article
|
A genetically defined model for human ovarian cancer.
|
Academic Article
|
Mammalian target of rapamycin.
|
Academic Article
|
Structure-activity relationships of fluorinated lysophosphatidic acid analogues.
|
Academic Article
|
A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
|
Academic Article
|
ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction.
|
Academic Article
|
Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma.
|
Academic Article
|
Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
|
Academic Article
|
Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation.
|
Academic Article
|
BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer.
|
Academic Article
|
Cytoplasmic expression of p21CIP1/WAF1 is correlated with IKKbeta overexpression in human breast cancers.
|
Academic Article
|
Point mutations of protein kinases and individualised cancer therapy.
|
Academic Article
|
Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
|
Academic Article
|
Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer.
|
Academic Article
|
A new mutational AKTivation in the PI3K pathway.
|
Academic Article
|
Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab.
|
Academic Article
|
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.
|
Academic Article
|
Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency.
|
Academic Article
|
Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression.
|
Academic Article
|
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.
|
Academic Article
|
Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers.
|
Academic Article
|
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.
|
Academic Article
|
A novel AKT3 mutation in melanoma tumours and cell lines.
|
Academic Article
|
Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model.
|
Academic Article
|
A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy.
|
Academic Article
|
A systems approach to analysis of molecular complexity in breast cancer.
|
Academic Article
|
Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells.
|
Academic Article
|
Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.
|
Academic Article
|
Phosphorylated 4E-BP1 is associated with poor survival in melanoma.
|
Academic Article
|
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.
|
Academic Article
|
Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors.
|
Academic Article
|
3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.
|
Academic Article
|
Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1.
|
Academic Article
|
ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS.
|
Academic Article
|
Future of personalized medicine in oncology: a systems biology approach.
|
Academic Article
|
Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2.
|
Academic Article
|
Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy.
|
Academic Article
|
PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer.
|
Academic Article
|
Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid.
|
Academic Article
|
Personalizing therapy for ovarian cancer: BRCAness and beyond.
|
Academic Article
|
Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer.
|
Academic Article
|
Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis.
|
Academic Article
|
Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer.
|
Academic Article
|
Activation of p21(CIP1/WAF1) in mammary epithelium accelerates mammary tumorigenesis and promotes lung metastasis.
|
Academic Article
|
Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis.
|
Academic Article
|
Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancer.
|
Academic Article
|
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
|
Academic Article
|
A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance.
|
Academic Article
|
Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals.
|
Academic Article
|
Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling.
|
Academic Article
|
Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms.
|
Academic Article
|
Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis.
|
Academic Article
|
A time-series DDP for functional proteomics profiles.
|
Academic Article
|
Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR.
|
Academic Article
|
Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancer.
|
Academic Article
|
MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition.
|
Academic Article
|
Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells.
|
Academic Article
|
Bioinformatics and systems biology.
|
Academic Article
|
Akt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57Kip2.
|
Academic Article
|
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer.
|
Academic Article
|
AKT-dependent phosphorylation of Niban regulates nucleophosmin- and MDM2-mediated p53 stability and cell apoptosis.
|
Academic Article
|
Abortive autophagy induces endoplasmic reticulum stress and cell death in cancer cells.
|
Academic Article
|
Development and validation of a prognostic gene-expression signature for lung adenocarcinoma.
|
Academic Article
|
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.
|
Academic Article
|
Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes.
|
Academic Article
|
Mask is required for the activity of the Hippo pathway effector Yki/YAP.
|
Academic Article
|
EVI1 splice variants modulate functional responses in ovarian cancer cells.
|
Academic Article
|
Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers.
|
Academic Article
|
Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer.
|
Academic Article
|
Inferring tumour purity and stromal and immune cell admixture from expression data.
|
Academic Article
|
CanDrA: cancer-specific driver missense mutation annotation with optimized features.
|
Academic Article
|
A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition.
|
Academic Article
|
Perturbation biology: inferring signaling networks in cellular systems.
|
Academic Article
|
Cancer Systems Biology: a peek into the future of patient care?
|
Academic Article
|
A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer.
|
Academic Article
|
End stage renal disease serum contains a specific renal cell growth factor.
|
Academic Article
|
Generation of cytotoxic lymphocytes to syngeneic tumors by using co-stimulator (Interleukin 2): in vivo activity.
|
Academic Article
|
CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C.
|
Academic Article
|
Transfection of human ovarian cancer cells with the HER-2/neu receptor tyrosine kinase induces a selective increase in PTP-H1, PTP-1B, PTP-alpha expression.
|
Academic Article
|
Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.
|
Academic Article
|
Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells.
|
Academic Article
|
CA 125: the past and the future.
|
Academic Article
|
The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells.
|
Academic Article
|
Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanisms.
|
Academic Article
|
Differential signaling by an anti-p185(HER2) antibody and heregulin.
|
Academic Article
|
Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer.
|
Academic Article
|
Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity.
|
Academic Article
|
Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.
|
Academic Article
|
Specific keynote: genome copy number abnormalities in ovarian cancer.
|
Academic Article
|
General keynote: molecular therapeutics and pharmocogenomics.
|
Academic Article
|
Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancer.
|
Academic Article
|
Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signaling.
|
Academic Article
|
Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.
|
Academic Article
|
Differential roles of phosphoinositide-dependent protein kinase-1 and akt1 expression and phosphorylation in breast cancer cell resistance to Paclitaxel, Doxorubicin, and gemcitabine.
|
Academic Article
|
Network topology determines dynamics of the mammalian MAPK1,2 signaling network: bifan motif regulation of C-Raf and B-Raf isoforms by FGFR and MC1R.
|
Academic Article
|
Sharpening the edges of understanding the structure/function of the LPA1 receptor: expression in cancer and mechanisms of regulation.
|
Academic Article
|
Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
|
Academic Article
|
Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms.
|
Academic Article
|
PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth.
|
Academic Article
|
Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers.
|
Academic Article
|
A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.
|
Academic Article
|
DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance.
|
Academic Article
|
Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression.
|
Academic Article
|
Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma.
|
Academic Article
|
Systematic analysis of genotype-specific drug responses in cancer.
|
Academic Article
|
Dissecting "PI3Kness": the complexity of personalized therapy for ovarian cancer.
|
Academic Article
|
Network inference using steady-state data and Goldbeter-Koshland kinetics. [corrected].
|
Academic Article
|
Bayesian inference of signaling network topology in a cancer cell line.
|
Academic Article
|
Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCa invasive signaling axis.
|
Academic Article
|
Proteomic classification of breast cancer.
|
Academic Article
|
The impact of tumor heterogeneity on patient treatment decisions.
|
Academic Article
|
BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.
|
Academic Article
|
Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps.
|
Academic Article
|
The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin.
|
Academic Article
|
Levels of soluble interleukin-2 receptor-alpha are elevated in serum and ascitic fluid from epithelial ovarian cancer patients.
|
Academic Article
|
Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase.
|
Academic Article
|
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
|
Academic Article
|
Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines.
|
Academic Article
|
An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer.
|
Academic Article
|
Translational research--traffic on the bridge.
|
Academic Article
|
Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
|
Academic Article
|
Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activity.
|
Academic Article
|
Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line.
|
Academic Article
|
Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.
|
Academic Article
|
Assessing BRCA carrier probabilities in extended families.
|
Academic Article
|
Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia.
|
Academic Article
|
Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis.
|
Academic Article
|
Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity.
|
Academic Article
|
Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.
|
Academic Article
|
Derailed endocytosis: an emerging feature of cancer.
|
Academic Article
|
Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition.
|
Academic Article
|
Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis.
|
Academic Article
|
Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer.
|
Academic Article
|
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.
|
Academic Article
|
Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells.
|
Academic Article
|
Subtype and pathway specific responses to anticancer compounds in breast cancer.
|
Academic Article
|
Interactions between tumor cells and microenvironment in breast cancer: a new opportunity for targeted therapy.
|
Academic Article
|
Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins.
|
Academic Article
|
Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapy.
|
Academic Article
|
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
|
Academic Article
|
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
|
Academic Article
|
Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival.
|
Academic Article
|
Intramural squamous cell carcinoma of the esophagus.
|
Academic Article
|
Phase II trial of amonafide in previously treated patients with advanced ovarian cancer: a Southwest Oncology Group study.
|
Academic Article
|
Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.
|
Academic Article
|
Comparison of the skin tumor-initiating activities of dihydrodiols and diol-epoxides of various polycyclic aromatic hydrocarbons.
|
Academic Article
|
The 10th International Conference on Monoclonal Antibody Immunoconjugates for Cancer: Radiodosimetry and Radiopharmaceuticals for Therapy.
|
Academic Article
|
A phase II trial of topotecan in esophageal carcinoma: a Southwest Oncology Group study (SWOG 9339).
|
Academic Article
|
Alterations in oncogenes, tumor suppressor genes, and growth factors associated with epithelial ovarian cancers.
|
Academic Article
|
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer.
|
Academic Article
|
Regulation of mRNA expression in breast cancer - a cis-tematic trans-action.
|
Academic Article
|
Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer.
|
Academic Article
|
LKB1 is a central regulator of tumor initiation and pro-growth metabolism in ErbB2-mediated breast cancer.
|
Academic Article
|
Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors.
|
Academic Article
|
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.
|
Academic Article
|
Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.
|
Academic Article
|
Concordance of genomic alterations between primary and recurrent breast cancer.
|
Academic Article
|
YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer.
|
Academic Article
|
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer?.
|
Academic Article
|
Genetic and pharmacological strategies to refunctionalize the von Hippel Lindau R167Q mutant protein.
|
Academic Article
|
A pan-cancer proteomic perspective on The Cancer Genome Atlas.
|
Academic Article
|
Influence of biospecimen variables on proteomic biomarkers in breast cancer.
|
Academic Article
|
A curated census of autophagy-modulating proteins and small molecules: candidate targets for cancer therapy.
|
Academic Article
|
Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer.
|
Academic Article
|
Autophagy mediates HIF2a degradation and suppresses renal tumorigenesis.
|
Academic Article
|
Peroxiredoxin-1 protects estrogen receptor a from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer.
|
Academic Article
|
The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF.
|
Academic Article
|
Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent?) a VEGFR2/PDGFR?/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial.
|
Academic Article
|
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors.
|
Academic Article
|
Integrated analysis of transcriptomes of cancer cell lines and patient samples reveals STK11/LKB1-driven regulation of cAMP phosphodiesterase-4D.
|
Academic Article
|
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.
|
Academic Article
|
hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness.
|
Academic Article
|
RADical response puts an exceptional responder in CHKmate: a synthetic lethal curative response to DNA-damaging chemotherapy?
|
Academic Article
|
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors.
|
Academic Article
|
Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions.
|
Academic Article
|
P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer.
|
Academic Article
|
Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1a and oxidative phosphorylation in melanoma.
|
Academic Article
|
OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets.
|
Academic Article
|
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
|
Academic Article
|
In silico prediction of physical protein interactions and characterization of interactome orphans.
|
Academic Article
|
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.
|
Academic Article
|
Spatial normalization of reverse phase protein array data.
|
Academic Article
|
a-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration.
|
Academic Article
|
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
|
Academic Article
|
Clinical actionability enhanced through deep targeted sequencing of solid tumors.
|
Academic Article
|
Prognostic relevance of acquired uniparental disomy in serous ovarian cancer.
|
Academic Article
|
Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
|
Academic Article
|
SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer.
|
Academic Article
|
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma.
|
Academic Article
|
Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies.
|
Academic Article
|
Characterization of the role Rab25 in energy metabolism and cancer using extracellular flux analysis and material balance.
|
Academic Article
|
A decision support framework for genomically informed investigational cancer therapy.
|
Academic Article
|
An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.
|
Academic Article
|
Nuclear PTEN tumor-suppressor functions through maintaining heterochromatin structure.
|
Academic Article
|
Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.
|
Academic Article
|
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials.
|
Academic Article
|
Clinical next generation sequencing to identify actionable aberrations in a phase I program.
|
Academic Article
|
PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients.
|
Academic Article
|
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.
|
Academic Article
|
ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.
|
Academic Article
|
Death-associated protein kinase 1 promotes growth of p53-mutant cancers.
|
Academic Article
|
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours.
|
Academic Article
|
Metabolic stress induces a Wnt-dependent cancer stem cell-like state transition.
|
Academic Article
|
The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform.
|
Academic Article
|
Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.
|
Academic Article
|
Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.
|
Academic Article
|
Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
|
Academic Article
|
Integrative Protein-Based Prognostic Model for Early-Stage Endometrioid Endometrial Cancer.
|
Academic Article
|
Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women.
|
Academic Article
|
Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.
|
Academic Article
|
Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.
|
Academic Article
|
Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal Women.
|
Academic Article
|
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.
|
Academic Article
|
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.
|
Academic Article
|
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.
|
Academic Article
|
Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing.
|
Academic Article
|
A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway.
|
Academic Article
|
Robust Selection Algorithm (RSA) for Multi-Omic Biomarker Discovery; Integration with Functional Network Analysis to Identify miRNA Regulated Pathways in Multiple Cancers.
|
Academic Article
|
TransVar: a multilevel variant annotator for precision genomics.
|
Academic Article
|
Glucose starvation induces mutation and lineage-dependent adaptive responses in a large collection of cancer cell lines.
|
Academic Article
|
Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations.
|
Academic Article
|
Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis.
|
Academic Article
|
Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance.
|
Academic Article
|
Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.
|
Academic Article
|
mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer.
|
Academic Article
|
Functional annotation of rare gene aberration drivers of pancreatic cancer.
|
Academic Article
|
Inferring causal molecular networks: empirical assessment through a community-based effort.
|
Academic Article
|
Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma.
|
Academic Article
|
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System.
|
Academic Article
|
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
|
Academic Article
|
Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function.
|
Academic Article
|
Multiplatform-based molecular subtypes of non-small-cell lung cancer.
|
Academic Article
|
Role of RPL39 in Metaplastic Breast Cancer.
|
Academic Article
|
The degree of intratumor mutational heterogeneity varies by primary tumor sub-site
|
Academic Article
|
PKCiota promotes ovarian tumor progression through deregulation of cyclin E
|
Academic Article
|
Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects
|
Academic Article
|
Nuclear PTEN tumor-suppressor functions through maintaining heterochromatin structure
|
Academic Article
|
Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation
|
Academic Article
|
Rab11-FIP1C is a critical negative regulator in ErbB2-mediated mammary tumor progression
|
Academic Article
|
An integrated molecular analysis of lung adenocarcinomas identifies potential therapeutic targets among TTF1-negative tumors, including DNA Repair Proteins and Nrf2
|
Academic Article
|
Messenger rna expression and methylation of candidate tumor-suppressor genes and risk of ovarian cancer-a case-control analysis
|
Academic Article
|
Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer
|
Academic Article
|
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set
|
Academic Article
|
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
|
Academic Article
|
Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.
|
Academic Article
|
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.
|
Academic Article
|
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers.
|
Academic Article
|
Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape.
|
Academic Article
|
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
|
Academic Article
|
Systematic Functional Annotation of Somatic Mutations in Cancer.
|
Academic Article
|
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.
|
Academic Article
|
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
|
Academic Article
|
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
|
Academic Article
|
A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer.
|
Academic Article
|
Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype.
|
Academic Article
|
Messenger RNA expression and methylation of candidate tumor-suppressor genes and risk of ovarian cancer-a case-control analysis.
|
Academic Article
|
An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.
|
Academic Article
|
Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer.
|
Academic Article
|
MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer.
|
Academic Article
|
PKCiota promotes ovarian tumor progression through deregulation of cyclin E.
|
Academic Article
|
Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer.
|
Academic Article
|
Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts.
|
Academic Article
|
Reply to M.P. Decatris et al.
|
Academic Article
|
New era of integrated cancer biomarker discovery using reverse-phase protein arrays.
|
Academic Article
|
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
|
Academic Article
|
Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies.
|
Academic Article
|
Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment.
|
Academic Article
|
Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells.
|
Academic Article
|
Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression.
|
Academic Article
|
Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol.
|
Academic Article
|
The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.
|
Academic Article
|
The ErbB2?Ex16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.
|
Academic Article
|
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.
|
Academic Article
|
Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients.
|
Academic Article
|
RCP induces Slug expression and cancer cell invasion by stabilizing ?1 integrin.
|
Academic Article
|
Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
|
Academic Article
|
Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.
|
Academic Article
|
Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer.
|
Academic Article
|
Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics.
|
Academic Article
|
AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.
|
Academic Article
|
Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway.
|
Academic Article
|
HSP70 Inhibition Limits FAK-Dependent Invasion and Enhances the Response to Melanoma Treatment with BRAF Inhibitors.
|
Academic Article
|
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors.
|
Academic Article
|
Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials.
|
Academic Article
|
High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer Subtype.
|
Academic Article
|
Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance.
|
Academic Article
|
Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT.
|
Academic Article
|
Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.
|
Academic Article
|
Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer.
|
Academic Article
|
Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p.
|
Academic Article
|
Transgenic Expression of the Mitochondrial Chaperone TNFR-associated Protein 1 (TRAP1) Accelerates Prostate Cancer Development.
|
Academic Article
|
Clinical outcomes based on multigene profiling in metastatic breast cancer patients.
|
Academic Article
|
Loss-of-function screens of druggable targetome against cancer stem-like cells.
|
Academic Article
|
Next-Generation Sequencing and Result Interpretation in Clinical Oncology: Challenges of Personalized Cancer Therapy.
|
Academic Article
|
Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer.
|
Academic Article
|
Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis.
|
Academic Article
|
Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays.
|
Academic Article
|
YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.
|
Academic Article
|
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
|
Academic Article
|
The rise of genomic profiling in ovarian cancer.
|
Academic Article
|
Neomorphic mutations create therapeutic challenges in cancer.
|
Academic Article
|
ERK and p38 MAPK Activities Determine Sensitivity to PI3K/mTOR Inhibition via Regulation of MYC and YAP.
|
Academic Article
|
A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers.
|
Academic Article
|
Integrated Molecular Characterization of Uterine Carcinosarcoma.
|
Academic Article
|
A murine preclinical syngeneic transplantation model for breast cancer precision medicine.
|
Academic Article
|
Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer.
|
Academic Article
|
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.
|
Academic Article
|
A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory.
|
Academic Article
|
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
|
Academic Article
|
Oncogenic RAS Regulates Long Noncoding RNA Orilnc1 in Human Cancer.
|
Academic Article
|
Molecular heterogeneity at the network level: high-dimensional testing, clustering and a TCGA case study.
|
Academic Article
|
Development and Validation of an Ultradeep Next-Generation Sequencing Assay for Testing of Plasma Cell-Free DNA from Patients with Advanced Cancer.
|
Academic Article
|
CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.
|
Academic Article
|
Functional variomics and network perturbation: connecting genotype to phenotype in cancer.
|
Academic Article
|
Identifying Abundant Immunotherapy and Other Targets in Solid Tumors: Integrating RNA-seq and Mass Spectrometry Proteomics Data Sets.
|
Academic Article
|
Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo.
|
Academic Article
|
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.
|
Academic Article
|
Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-?B Pathway in Melanoma.
|
Academic Article
|
PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer.
|
Academic Article
|
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
|
Academic Article
|
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer.
|
Academic Article
|
Erratum: Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo.
|
Academic Article
|
Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
|
Academic Article
|
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response.
|
Academic Article
|
Precision oncology: neither a silver bullet nor a dream.
|
Academic Article
|
Comprehensive Characterization of Alternative Polyadenylation in Human Cancer.
|
Academic Article
|
A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles.
|
Academic Article
|
Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas.
|
Academic Article
|
"Personalized Cancer Therapy": A Publicly Available Precision Oncology Resource.
|
Academic Article
|
A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.
|
Academic Article
|
Physician interpretation of genomic test results and treatment selection.
|
Academic Article
|
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
|
Academic Article
|
ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma.
|
Academic Article
|
Surviving Ovarian Cancer: An Affair between Defective DNA Repair and RB1.
|
Academic Article
|
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes.
|
Academic Article
|
Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers.
|
Academic Article
|
The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.
|
Academic Article
|
Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded Antibodies.
|
Academic Article
|
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency.
|
Academic Article
|
EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation.
|
Academic Article
|
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade.
|
Academic Article
|
Cancer driver mutation prediction through Bayesian integration of multi-omic data.
|
Academic Article
|
Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.
|
Academic Article
|
Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing.
|
Academic Article
|
Rab25 augments cancer cell invasiveness through a ?1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.
|
Academic Article
|
Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma.
|
Academic Article
|
Survival of Cancer Stem-Like Cells Under Metabolic Stress via CaMK2a-mediated Upregulation of Sarco/Endoplasmic Reticulum Calcium ATPase Expression.
|
Academic Article
|
Precision Oncology Decision Support: Current Approaches and Strategies for the Future.
|
Academic Article
|
Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro.
|
Academic Article
|
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma.
|
Academic Article
|
BRD4 facilitates replication stress-induced DNA damage response.
|
Academic Article
|
Autotaxin exacerbates tumor progression by enhancing MEK1 and overriding the function of miR-489-3p.
|
Academic Article
|
Targeting gamma secretase: has progress moved up a Notch?
|
Academic Article
|
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.
|
Academic Article
|
RNA editing derived epitopes function as cancer antigens to elicit immune responses.
|
Academic Article
|
Systems biology approach reveals a link between mTORC1 and G2/M DNA damage checkpoint recovery.
|
Academic Article
|
Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance.
|
Academic Article
|
?-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer.
|
Academic Article
|
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells.
|
Academic Article
|
BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors.
|
Academic Article
|
Author Correction: Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer.
|
Academic Article
|
Credentialing Individual Samples for Proteogenomic Analysis.
|
Academic Article
|
Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer.
|
Academic Article
|
Defective Replication Stress Response Is Inherently Linked to the Cancer Stem Cell Phenotype.
|
Academic Article
|
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.
|
Academic Article
|
MERIT: Systematic Analysis and Characterization of Mutational Effect on RNA Interactome Topology.
|
Academic Article
|
State-of-the-art strategies for targeting the DNA damage response in cancer.
|
Academic Article
|
Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer.
|
Academic Article
|
Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer.
|
Academic Article
|
Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models.
|
Academic Article
|
PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness.
|
Academic Article
|
Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis.
|
Academic Article
|
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.
|
Academic Article
|
Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies.
|
Academic Article
|
Implementing a comprehensive translational oncology platform: from molecular testing to actionability.
|
Academic Article
|
Personalized Integrated Network Modeling of the Cancer Proteome Atlas.
|
Academic Article
|
PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma.
|
Academic Article
|
Genome-Wide Analysis of Head and Neck Squamous Cell Carcinomas Reveals HPV, TP53, Smoking and Alcohol-Related Allele-Based Acquired Uniparental Disomy Genomic Alterations.
|
Academic Article
|
Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient-Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness.
|
Academic Article
|
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference.
|
Academic Article
|
AKT isoform-specific expression and activation across cancer lineages.
|
Academic Article
|
Olaparib and a-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial.
|
Academic Article
|
Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium.
|
Academic Article
|
Prospective Clinical Sequencing of Adult Glioma.
|
Academic Article
|
Protein Kinase C Quality Control by Phosphatase PHLPP1?Unveils Loss-of-Function Mechanism in Cancer.
|
Academic Article
|
Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity.
|
Academic Article
|
GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and ?-catenin activity.
|
Academic Article
|
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer.
|
Academic Article
|
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer.
|
Academic Article
|
Breast cancer quantitative proteome and proteogenomic landscape.
|
Academic Article
|
Integrated transcriptomic-genomic tool Texomer profiles cancer tissues.
|
Academic Article
|
Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors.
|
Academic Article
|
Next-generation characterization of the Cancer Cell Line Encyclopedia.
|
Concept
|
Tumor Suppressor p53-Binding Protein 1
|
Concept
|
Tumor Hypoxia
|
Concept
|
Circulating Tumor DNA
|
Concept
|
Tumor Microenvironment
|
Concept
|
Neoplasm Grading
|
Concept
|
Triple Negative Breast Neoplasms
|
Concept
|
Response Evaluation Criteria in Solid Tumors
|
Academic Article
|
Advancing Drug Development in Gynecologic Malignancies.
|
Academic Article
|
The DNA Endonuclease Mus81 Regulates ZEB1 Expression and Serves as a Target of BET4 Inhibitors in Gastric Cancer.
|
Academic Article
|
Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy.
|
Academic Article
|
TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data.
|
Academic Article
|
Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling.
|
Academic Article
|
Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation.
|
Academic Article
|
COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms.
|
Academic Article
|
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases.
|
Academic Article
|
Comprehensive characterization of circular RNAs in ~?1000 human cancer cell lines.
|
Academic Article
|
Identification and validation of a prognostic proteomic signature for cervical cancer.
|
Academic Article
|
Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion.
|
Academic Article
|
Proteomics advances for precision therapy in ovarian cancer.
|
Academic Article
|
Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations.
|
Academic Article
|
Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer.
|
Academic Article
|
Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study.
|
Academic Article
|
MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis.
|
Academic Article
|
A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis.
|
Academic Article
|
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer.
|
Academic Article
|
Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma.
|
Academic Article
|
Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers.
|
Academic Article
|
Using Reverse Phase Protein Array (RPPA) to Identify and Target Adaptive Resistance.
|
Academic Article
|
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer.
|
Academic Article
|
Characterization of Hypoxia-associated Molecular Features to Aid Hypoxia-Targeted Therapy.
|
Academic Article
|
PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis.
|
Academic Article
|
Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma.
|
Academic Article
|
Comprehensive assessment of computational algorithms in predicting cancer driver mutations.
|
Academic Article
|
Immuno-genomic landscape of osteosarcoma.
|
Academic Article
|
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer.
|
Academic Article
|
Comparison of Real-Time Fluorescence Confocal Digital Microscopy With Hematoxylin-Eosin-Stained Sections of Core-Needle Biopsy Specimens.
|
Academic Article
|
Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts.
|
Academic Article
|
Verteporfin Inhibits PD-L1 through Autophagy and the STAT1-IRF1-TRIM28 Signaling Axis, Exerting Antitumor Efficacy.
|
Academic Article
|
Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression.
|
Academic Article
|
Sex-associated molecular differences for cancer immunotherapy.
|
Academic Article
|
Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer.
|
Academic Article
|
Predicting Cancer Cell Line Dependencies From the Protein Expression Data of Reverse-Phase Protein Arrays.
|
Academic Article
|
Which path to follow? Utilizing proteomics to improve therapy choices for breast cancer patients.
|
Academic Article
|
Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-?B1 Target SerpinE1 in Aggressive Glioblastoma Tumors.
|
Academic Article
|
Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis.
|
Academic Article
|
p85? regulates autophagic degradation of AXL to activate oncogenic signaling.
|
Academic Article
|
Systems approach to rational combination therapy: PARP inhibitors.
|
Academic Article
|
MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling.
|
Academic Article
|
BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis.
|
Academic Article
|
Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways.
|
Academic Article
|
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models.
|
Academic Article
|
RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC.
|
Academic Article
|
Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes.
|
Academic Article
|
The roles of MAGEA6 variants in pancreatic cancer development and their potential impact on cancer immunotherapy.
|
Academic Article
|
Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma.
|
Academic Article
|
Integrated Genomic Characterization of the Human Immunome in Cancer.
|
Academic Article
|
Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and response.
|
Academic Article
|
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy.
|
Academic Article
|
Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors.
|
Academic Article
|
Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA.
|
Academic Article
|
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling.
|
Academic Article
|
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer.
|
Academic Article
|
Transient commensal clonal interactions can drive tumor metastasis.
|
Academic Article
|
Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines.
|
Academic Article
|
Genetic alterations and expression characteristics of ARID1A impact tumor immune contexture and survival in early-onset gastric cancer.
|
Academic Article
|
Hormonal modulation of ESR1 mutant metastasis.
|
Academic Article
|
Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models.
|
Academic Article
|
MEK Inhibition Remodels the Immune Landscape of Mutant KRAS Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors.
|
Academic Article
|
Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profiling.
|
Academic Article
|
Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy.
|
Academic Article
|
Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer.
|
Academic Article
|
Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response.
|
Academic Article
|
mi-IsoNet: systems-scale microRNA landscape reveals rampant isoform-mediated gain of target interaction diversity and signaling specificity.
|
Academic Article
|
Spatially interacting phosphorylation sites and mutations in cancer.
|
Academic Article
|
Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.
|
Academic Article
|
Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers.
|
Academic Article
|
Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer.
|
Academic Article
|
Relationship Between Response and Dose in Published, Contemporary Phase I Oncology Trials.
|
Academic Article
|
In Situ Tumor Vaccination with Nanoparticle Co-Delivering CpG and STAT3 siRNA to Effectively Induce Whole-Body Antitumor Immune Response.
|
Academic Article
|
Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors.
|
Academic Article
|
Ex Vivo Analysis of Primary Tumor Specimens for Evaluation of Cancer Therapeutics.
|
Academic Article
|
Exceptional Response to Trastuzumab in a Heavily Pretreated Patient With ERBB3-Mutated Metastatic Breast Cancer.
|
Academic Article
|
Uncoupling of gene expression from copy number presents therapeutic opportunities in aneuploid cancers.
|
Academic Article
|
Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance.
|
Academic Article
|
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer.
|
Academic Article
|
Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer.
|
Academic Article
|
TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors.
|
Academic Article
|
CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models.
|
Academic Article
|
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in Gliomas.
|
Academic Article
|
BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulators.
|
Academic Article
|
The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.
|
Academic Article
|
Expression of chimeric antigen receptor therapy targets detected by single-cell sequencing of normal cells may contribute to off-tumor toxicity.
|
Academic Article
|
Interleukin enhancer-binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma.
|
Academic Article
|
Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.
|
Academic Article
|
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway.
|
Academic Article
|
Mechanical Stress Signaling in Pancreatic Cancer Cells Triggers p38 MAPK- and JNK-Dependent Cytoskeleton Remodeling and Promotes Cell Migration via Rac1/cdc42/Myosin II.
|
Academic Article
|
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer.
|
Academic Article
|
Whole-chromosome arm acquired uniparental disomy in cancer development is a consequence of isochromosome formation.
|
Academic Article
|
An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer.
|
Academic Article
|
Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in Gliomas.
|
Academic Article
|
Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival.
|
Academic Article
|
Characterization of anticancer drug resistance by reverse-phase protein array: new targets and strategies.
|
Academic Article
|
Systematic discovery of mutation-directed neo-protein-protein interactions in cancer.
|
Academic Article
|
PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia.
|
Academic Article
|
Inhibiting the IRE1a Axis of the Unfolded Protein Response Enhances the Antitumor Effect of AZD1775 in TP53 Mutant Ovarian Cancer.
|
Academic Article
|
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs.
|
Academic Article
|
HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors.
|
Academic Article
|
Biomolecular Condensation: A New Phase in Cancer Research.
|
Academic Article
|
Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment.
|
Academic Article
|
A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells.
|
Academic Article
|
Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets.
|
Academic Article
|
BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancer.
|
Academic Article
|
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance.
|
Academic Article
|
In vivo functional characterization of EGFR variants identifies novel drivers of glioblastoma.
|
Academic Article
|
Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer.
|
Academic Article
|
Panobinostat Induced Spatial In Situ Biomarkers Predictive of Anti-PD-1 Efficacy in Mouse Mammary Carcinoma.
|
Academic Article
|
IMP1/IGF2BP1 in human colorectal cancer extracellular vesicles.
|
Academic Article
|
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study.
|
Academic Article
|
PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived models.
|
Academic Article
|
Stiff matrix induces exosome secretion to promote tumour growth.
|
Academic Article
|
Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma.
|
Academic Article
|
BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors.
|
Academic Article
|
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
|
Academic Article
|
Selective enrichment of plasma cell-free messenger RNA in cancer-associated extracellular vesicles.
|
Academic Article
|
MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer.
|
Academic Article
|
Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer.
|
Academic Article
|
Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma.
|
Academic Article
|
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity.
|
Academic Article
|
Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins.
|
Academic Article
|
Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevance.
|